$ACMR

Wang David H sold $110K of ACMR

Wang David H (See Remarks) sold 1,187 shares of ACM Research, Inc. (ACMR) at $93.04 ($0.11M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosure provides a data point on insider activity but does not, by itself, change the company’s fundamentals or forward outlook.

02

Market read

Expect minimal fundamental impact; any price effect is likely sentiment-driven and short-lived given 10b5-1 context.

03

What to watch

Traders may overreact to Form 4 volume; the key is whether there are repeated sales/buys around the same period or any concurrent fundamental catalysts.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed June 5 (sale executed June 3)

Background

This is a routine SEC Form 4 insider transaction for ACM Research, Inc. (ACMR), reported as an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR insider David H. Wang sold 1,187 shares in an open-market transaction disclosed via SEC Form 4 on June 3, 2026.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless accompanied by other company-specific news.

Evidence & confidence

The filing is an ownership-change disclosure (Form 4) with an explicit 10b5-1 plan, which reduces the likelihood of information asymmetry.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is pre-arranged under 10b5-1, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • ACM Research, Inc.

    Subject of the insider transaction disclosure (Form 4).

  • David H. Wang

    Officer/Director/10% owner who sold shares; transaction executed June 3, 2026.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.